Lanean...
Re-assessing ZNF331 as a DNA methylation biomarker for colorectal cancer
We have previously shown that aberrant promoter methylation of ZNF331 is a potential biomarker for colorectal cancer detection with high sensitivity (71%) and specificity (98%). This finding was recently confirmed by others, and it was additionally suggested that promoter methylation of ZNF331 was a...
Gorde:
| Argitaratua izan da: | Clin Epigenetics |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BioMed Central
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5975481/ https://ncbi.nlm.nih.gov/pubmed/29854011 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13148-018-0503-2 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|